| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 1207360-89-1 | GDC-0349(RG7603) |
≥98% | | 询价 |
| 2 | 1062159-35-6 | WAY-600 |
≥98% | | 询价 |
| 3 | 1062161-90-3 | WYE-687 |
≥98% | | 询价 |
| 4 | 1254036-66-2 | GSK2292767 |
≥98% | | 询价 |
| 5 | 1386874-06-1 | Samotolisib(LY3023414 GTPL8918) |
≥98% | | 询价 |
| 6 | 1620576-64-8 | AZD8835 |
≥98% | | 询价 |
| 7 | 522-17-8 | Deguelin |
≥98% | | 询价 |
| 8 | 1429639-50-8 | CZ415 |
≥98% | | 询价 |
| 9 | 1382979-44-3 | GDC-0084(Paxalisib RG7666) |
≥98% | | 询价 |
| 10 | 1092788-83-4 | PP121 |
≥98% | | 询价 |
| 11 | 914913-88-5 | Palomid 529(P-529,SG00-529) |
≥98% | | 询价 |
| 12 | 1144068-46-1 | WYE125132(WYE132) |
≥98% | | 询价 |
| 13 | 1009298-59-2 | Vistusertib(AZD2014) |
≥98% | | 询价 |
| 14 | 1062169-56-5 | WYE-354 |
≥98% | | 询价 |
| 15 | 936890-98-1 | OSI-027(ASP-4786,CERC-006,AEVI-006) |
≥98% | | 询价 |
| 16 | 1222998-36-8 | Torin 1 |
≥98% | | 询价 |
| 17 | 1224844-38-5 | Sapanisertib(NK128 MLN0128 TAK228) |
≥98% | | 询价 |
| 18 | 572924-54-0 | Ridaforolimus(Deforolimus,MK8669,AP23573) |
≥98% | | 询价 |
| 19 | 104987-11-3 | Tacrolimus(FK-506,Fujimycin,FR900506,Prograf) |
≥98% | | 询价 |
| 20 | 938440-64-3 | KU-0063794 |
≥98% | | 询价 |
| 21 | 162635-04-3 | Temsirolimus(CCI779,NSC683864) |
≥98% | | 询价 |
| 22 | 1009298-09-2 | AZD8055 |
≥98% | | 询价 |
| 23 | 1092351-67-1 | Torkinib(PP242) |
≥98% | | 询价 |
| 24 | 159351-69-6 | Everolimus(RAD-001,SDZ-RAD) |
≥98% | | 询价 |
| 25 | 53123-88-9 | Rapamycin(Sirolimus AY22989) |
≥98% | | 询价 |
| 26 | 612847-09-3 | Akti-1/2(AKT inhibitor VIII) |
≥98% | | 询价 |
| 27 | 1616632-77-9 | TIC10(imipridone,ONC201,NSC350625) |
≥98% | | 询价 |
| 28 | 305834-79-1 | SC79 |
≥98% | | 询价 |
| 29 | 1056901-62-2 | AT13148 |
≥98% | | 询价 |
| 30 | 1047644-62-1 | Afuresertib(GSK-2110183) |
≥98% | | 询价 |
| 31 | 41276-02-2 | TIC10 Analogue |
≥98% | | 询价 |
| 32 | 58066-85-6 | Miltefosine |
≥98% | | 询价 |
| 33 | 1191951-57-1 | PHT-427(CS-0223) |
≥98% | | 询价 |
| 34 | 2414909-94-5 | RETV804M kinase inhibitor |
≥98% | | 询价 |
| 35 | 1675204-51-9 | BMS-242 |
≥98% | | 询价 |
| 36 | 1268524-71-5 | (-)-JQ-1 |
≥98% | | 询价 |
| 37 | 1818314-88-3 | BMS-1166 |
≥98% | | 询价 |
| 38 | 2421117-98-6 | BC-DXI-843 |
≥98% | | 询价 |
| 39 | 146479-72-3 | Follicle-stimulating hormone |
≥98% | | 询价 |
| 40 | 1353563-85-5 | AUNP-12 |
≥98% | | 询价 |
| 41 | 5608-24-2 | PRIMA-1 |
≥98% | | 询价 |
| 42 | 1235034-55-5 | A-1155463 |
≥98% | | 询价 |
| 43 | 1430844-80-6 | A-1331852 |
≥98% | | 询价 |
| 44 | 1821496-27-8 | BDA-366 |
≥98% | | 询价 |
| 45 | 1313363-54-0 | NVP-CGM097 |
≥98% | | 询价 |
| 46 | 1629654-95-0 | PD-1/PD-L1 Inhibitor 3 |
≥98% | | 询价 |
| 47 | 2244678-29-1 | TH257 |
≥98% | | 询价 |
| 48 | 2752453-58-8 | Metallo-β-lactamase-IN-7 |
≥98% | | 询价 |
| 49 | 1439899-44-1 | Metallo-β-lactamase-IN-6 |
≥98% | | 询价 |
| 50 | 94035-02-6 | Hydroxypropyl-beta-cyclodextrin |
≥98% | | 询价 |
| 51 | 63675-72-9 | Nisoldipine |
≥98% | | 询价 |
| 52 | 608141-41-9 | Apremilast |
≥98% | | 询价 |
| 53 | 1234015-57-6 | Prexasertib mesylate hydrate(LY 2606368) |
≥98% | | 询价 |
| 54 | 1234015-54-3 | Prexasertib 2HCl(LY-2606368) |
≥98% | | 询价 |
| 55 | 1234015-55-4 | Prexasertib mesylate(LY-2606368 mesylate) |
≥98% | | 询价 |
| 56 | 161058-83-9 | NU2058 |
≥98% | | 询价 |
| 57 | 1092939-16-6 | Ruxolitinib sulfate(INC 424,INCB 18424,INCB 018424,Jakafi,Jakavi) |
≥98% | | 询价 |
| 58 | 1092939-17-7 | Ruxolitinib Phosphate(INC-424,INCB-18424,INCB-018424,Jakafi and Jakavi) |
≥98% | | 询价 |
| 59 | 2089288-03-7 | AZD1390 |
≥98% | | 询价 |
| 60 | 871361-88-5 | SC66 |
≥98% | | 询价 |
m.cnreagent.com